HealthInvest Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

HealthInvest Partners’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-78,905	Closed	-$8.31M	–	16
2016 Q4	$8.31M	Sell	78,905 -6,300	-7%	-$660K	7.65%	6
2016 Q3	$9.42M	Sell	85,205 -1,000	-1%	-$132K	7.01%	10
2016 Q2	$12.6M	Sell	86,205 -7,800	-8%	-$1.11M	5.76%	9
2016 Q1	$13.5M	Buy	+94,005	New	+$13.4M	6.31%	8

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

HealthInvest Partners's TARO Position: Q1 2017 in Review

HealthInvest Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2017, closing a stake of 78,905 shares — an estimated $8.31M sold.

HealthInvest Partners first reported a position in TARO in Q1 2016 and held it in 4 quarters. The position peaked at $13.5M in Q1 2016. 139 funds tracked by Wall St. Rank hold TARO as of Q1 2017.

HealthInvest Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2017 after selling out during the quarter.
HealthInvest Partners sold 78,905 Taro Pharmaceutical Industries Ltd. shares in Q1 2017, an estimated $8.31M.
HealthInvest Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 4 quarters.
HealthInvest Partners's Taro Pharmaceutical Industries Ltd. position peaked at $13.5M in Q1 2016.
139 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2017.

Based on HealthInvest Partners's 13F filing for Q1 2017, filed 28 Apr 2017.